Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 143

1.

Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections.

Pederson RA, McIntosh CH.

J Diabetes Investig. 2016 Apr;7 Suppl 1:4-7. doi: 10.1111/jdi.12480. Epub 2016 Mar 14. Review.

2.

High Trans Kinetic Selectivity in Ruthenium-Based Olefin Cross-Metathesis through Stereoretention.

Johns AM, Ahmed TS, Jackson BW, Grubbs RH, Pederson RL.

Org Lett. 2016 Feb 19;18(4):772-5. doi: 10.1021/acs.orglett.6b00031. Epub 2016 Feb 3.

PMID:
26840878
3.

Interoperable Archetypes With a Three Folded Terminology Governance.

Pederson R, Ellingsen G.

Stud Health Technol Inform. 2015;216:934.

PMID:
26262236
4.

Implementation frameworks and MSW curricula: encouraging pursuit and use of model pertinent data.

Bertram RM, King K, Pederson R, Nutt J.

J Evid Based Soc Work. 2014;11(1-2):193-207. doi: 10.1080/15433714.2013.850324.

PMID:
24405143
5.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

6.

Concise syntheses of insect pheromones using Z-selective cross metathesis.

Herbert MB, Marx VM, Pederson RL, Grubbs RH.

Angew Chem Int Ed Engl. 2013 Jan 2;52(1):310-4. doi: 10.1002/anie.201206079. Epub 2012 Oct 10.

7.

Effectiveness and spillover of an after-school health promotion program for Hispanic elementary school children.

de Heer HD, Koehly L, Pederson R, Morera O.

Am J Public Health. 2011 Oct;101(10):1907-13. doi: 10.2105/AJPH.2011.300177. Epub 2011 Aug 18.

8.

Low catalyst loadings in olefin metathesis: synthesis of nitrogen heterocycles by ring-closing metathesis.

Kuhn KM, Champagne TM, Hong SH, Wei WH, Nickel A, Lee CW, Virgil SC, Grubbs RH, Pederson RL.

Org Lett. 2010 Mar 5;12(5):984-7. doi: 10.1021/ol9029808.

9.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators.

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
10.

Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.

Gelling RW, Vuguin PM, Du XQ, Cui L, Rømer J, Pederson RA, Leiser M, Sørensen H, Holst JJ, Fledelius C, Johansen PB, Fleischer N, McIntosh CH, Nishimura E, Charron MJ.

Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E695-707. doi: 10.1152/ajpendo.00082.2009. Epub 2009 Jul 14.

11.

Right ventricular gunshot wound with retrograde embolization.

McLaughlin RL, Analitis S, VanVleet S, Pederson R.

J Trauma Nurs. 2008 Jul-Sep;15(3):123-5. doi: 10.1097/01.JTN.0000337154.16088.6d.

PMID:
18820560
12.

Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat.

Piteau S, Olver A, Kim SJ, Winter K, Pospisilik JA, Lynn F, Manhart S, Demuth HU, Speck M, Pederson RA, McIntosh CH.

Biochem Biophys Res Commun. 2007 Nov 3;362(4):1007-12. Epub 2007 Aug 29.

PMID:
17803965
13.

Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM).

Hinke SA, Pederson RA, McIntosh CH.

Adv Exp Med Biol. 2006;575:119-33. Review. No abstract available.

PMID:
16700515
14.

Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus.

McIntosh CH, Demuth HU, Kim SJ, Pospisilik JA, Pederson RA.

Int J Biochem Cell Biol. 2006;38(5-6):860-72. Epub 2006 Jan 11. Review.

PMID:
16442340
15.

Effects of cooperative learning strategy on undergraduate kinesiology students' learning styles.

Meeuwsen HJ, King GA, Pederson R.

Percept Mot Skills. 2005 Oct;101(2):525-30.

PMID:
16383090
16.

Type 2 diabetes--therapy with dipeptidyl peptidase IV inhibitors.

Demuth HU, McIntosh CH, Pederson RA.

Biochim Biophys Acta. 2005 Aug 1;1751(1):33-44. Review.

PMID:
15978877
17.

Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?

McIntosh CH, Demuth HU, Pospisilik JA, Pederson R.

Regul Pept. 2005 Jun 15;128(2):159-65. Review.

PMID:
15780435
18.

In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide.

Hinke SA, Manhart S, Speck M, Pederson RA, Demuth HU, McIntosh CH.

Life Sci. 2004 Aug 27;75(15):1857-70.

PMID:
15302229
19.

[Ser2]- and [SerP2] incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in vitro and in vivo.

Hinke SA, Manhart S, Kühn-Wache K, Nian C, Demuth HU, Pederson RA, McIntosh CH.

J Biol Chem. 2004 Feb 6;279(6):3998-4006. Epub 2003 Nov 10.

20.

Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase.

Ehses JA, Casilla VR, Doty T, Pospisilik JA, Winter KD, Demuth HU, Pederson RA, McIntosh CH.

Endocrinology. 2003 Oct;144(10):4433-45. Epub 2003 Jun 19.

PMID:
12960055
Items per page

Supplemental Content

Loading ...
Write to the Help Desk